The NIH Blueprint Neurotherapeutics Network (BPN) has initiated a series of collaborative drug discovery and development projects focused on nervous system disorders. These projects will be developing therapeutic leads through an iterative process of medicinal chemistry optimization and in vitro and in vivo testing. A component of this process will be the conduct of pharmacokinetic (PK) and toxicity assessment of compounds developed through the BPN. This task will cover all tasks related to general contract administration for the period of 9/13/2012-9/12/2013.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research and Development Contracts (N01)
Project #
271201100004I-0-27100002-1
Application #
8561550
Study Section
Project Start
2012-09-13
Project End
2016-09-12
Budget Start
Budget End
Support Year
Fiscal Year
2012
Total Cost
$121,795
Indirect Cost
Name
Sri International
Department
Type
DUNS #
009232752
City
Menlo Park
State
CA
Country
United States
Zip Code
94025